ABSTRACT
Introduction Prevalence of possible sarcopenia is estimated to be significantly higher in community-dwelling older adults than that of confirmed or severe sarcopenia. However, there are currently far fewer non-pharmacological intervention strategies for possible sarcopenia than for sarcopenia in the community. Meanwhile, one type of non-pharmacological intervention in sarcopenic area, health education, is under-researched, and older people’s awareness about sarcopenia is extremely low, necessitating an immediate dissemination tool for prevention. Social media may be a potential, scalable, low-cost tool for this. This study protocol outlines how a social media-based multicomponent intervention will be co-designed with stakeholders to address this evidence gap.
Methods and analysis Guided by the Medical Research Council’s framework, the proposed research covers two phases that employ a co-design approach to develop a theory-based multicomponent intervention to increase sarcopenia prevention in the community. The participants will be recruited from young-old adults (60∼69) with possible sarcopenia in the community of Changsha, China. Maximum sample size will be 45 participants in total, with 18∼25 participants in the development phase and 15∼20 participants in the pre-testing phase. During two rounds of focus groups with older adults, a social-media based intervention strategy will be developed from a theory-based conceptual model and an initial intervention plan formulated by the research group. After this, there will be a three-week pre-testing phase, followed by a semi-structured interview to further modify the theory-based conceptual model and the social-media based intervention strategy. The focus of the data analysis will be on thematic analysis of qualitative data primarily derived from the group interview and the semi-structured interview with key stakeholders.
Ethics and dissemination This study has been approved by the University of Manchester Research Ethics Committee (Project ID: 15664), and permissions have already been granted by collaborators in relevant Chinese organisations. We will collaborate with stakeholders to inform our dissemination strategy and co-present our findings (e.g., at community events or through social media). Furthermore, we will disseminate our findings to academics and healthcare professionals via webinars, academic conferences, and peer-reviewed publications.
Strengths and limitations of this study
- This is the first study to develop a health education and exercise intervention aimed at improving muscle function in community-dwelling young-old adults with possible sarcopenia.
- This is the first study in the sarcopenic area to develop a multicomponent intervention for sarcopenia prevention based on social media (TikTok).
- This study addresses some shortcomings of single text or audio materials or lengthy lessons in current health education for sarcopenia with short videos.
- This study employs co-design to ensure that the intervention strategy is acceptable to relevant stakeholders and meets their needs by soliciting their input.
- The sample size will be small that it may not be representative of the entire Chinese older population.
- This study will not draw any conclusions about the intervention effectiveness due to the short duration of the pre-testing phase.
- The study findings are unique to the community setting and population in China and may not be generalised to other settings or countries.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The funders did not and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study has been approved by the University of Manchester Research Ethics Committee (Project ID: 15664).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Ya Shi: ya.shi{at}postgrad.manchester.ac.uk
Emma Stanmore: emma.stanmore{at}manchester.ac.uk
Lisa Mcgarrigle: lisa.mcgarrigle{at}manchester.ac.uk
Chris Todd: chris.todd{at}manchester.ac.uk
Twitter
Emma Stanmore @emmastanmore
Lisa McGarrigle @mcgarrigle_lisa
Chris Todd @Prof_Chris_Todd
Funding This work was supported by The University of Manchester-China Scholarship Council Joint Scholarship. The funder has had no involvement in any aspect of the protocol or the decision to submit for publication and will not be involved in the study. Grant number: 202108320049.This paper presents independent research part funded by a National Institute for Health and Care Research Senior Investigator Award to Prof Todd (NIHR200299). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.
Competing interests None declared.
Patient and public involvement Patients and/or the public will be involved in the co-design, or conduct, or reporting, or dissemination plans of this research. Refer to the Methods section for further details.
Consent for publication All authors approved the submission.
Provenance and peer review Not commissioned; externally peer reviewed.
Data Availability
No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.
